# A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)

> **NCT01589029** · PHASE1 · TERMINATED · sponsor: **PD Dr. med. Stephan Michels** · enrollment: 6 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **DRUG:** CANAKINUMAB (ILARIS®)

## Key facts

- **NCT ID:** NCT01589029
- **Lead sponsor:** PD Dr. med. Stephan Michels
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-04
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** The results of the interim analysis showed that the primary endpoint was not met
- **Last updated:** 2015-11-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01589029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01589029, "A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01589029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*